Identification of selective nanomolar inhibitors of the human neuraminidase, NEU4

ACS Medicinal Chemistry Letters

Volumn 4, Issue 6, 2013, Pages 532-537

  Albohy, Amgad ^a   Zhang, Yi ^a   Smutova, Victoria ^b,c   Pshezhetsky, Alexey V ^b,c   Cairo, Christopher W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Glycosyl hydrolase; Inhibitors; NEU1; NEU2; NEU3; NEU4; Neuraminidase; Sialic acid; Sialidase

Indexed keywords

(5 ACETAMIDO 9 [4 HYDROXYMETHYL(1,2,3)TRIAZOL 1 YL] 2,3,5,9 TETRADEOXY D GLYCERO D GALACTO 2 NONULOPYRANOSONIC ACID; ISOENZYME; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG POTENCY; DRUG SCREENING; ENZYME INHIBITION; HUMAN; IC 50; IN VITRO STUDY; PRIORITY JOURNAL;

EID: 84879072241     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml400080t     Document Type: Article

References (33)

1. von Itzstein, M. The war against influenza: discovery and development of sialidase inhibitors. Nat. Rev. Drug Discovery 2007, 6, 967-974.
2. Pshezhetsky, A. V.; Richard, C.; Michaud, L.; Igdoura, S.; Wang, S. P.; Elsliger, M. A.; Qu, J. Y.; Leclerc, D.; Gravel, R.; Dallaire, L.; Potier, M. Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis. Nat. Genet. 1997, 15, 316-320.
3. Monti, E.; Bonten, E.; D'Azzo, A.; Bresciani, R.; Venerando, B.; Borsani, G.; Schauer, R.; Tettamanti, G. Sialidases in Vertebrates: A Family Of Enzymes Tailored For Several Cell Functions. Advances in Carbohydrate Chemistry and Biochemistry; Academic Press: 2010; Vol. 64, pp 403-479.
4. Pshezhetsky, A. V.; Hinek, A. Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors. Glycoconjugate J. 2011, 28, 441-452.
5. Miyagi, T.; Yamaguchi, K. Mammalian sialidases: Physiological and pathological roles in cellular functions. Glycobiology 2012, 22, 880-896.
6. Gadhoum, S. Z.; Sackstein, R. CD15 expression in human myeloid cell differentiation is regulated by sialidase activity. Nat. Chem. Biol. 2008, 4, 751-757.
7. Seyrantepe, V.; Iannello, A.; Liang, F.; Kanshin, E.; Jayanth, P.; Samarani, S.; Szewczuk, M. R.; Ahmad, A.; Pshezhetsky, A. V. Regulation of Phagocytosis in Macrophages by Neuraminidase 1. J. Biol. Chem. 2010, 285, 206-215.
8. Jansen, A. J. G.; Josefsson, E. C.; Rumjantseva, V.; Liu, Q. P.; Falet, H.; Bergmeier, W.; Cifuni, S. M.; Sackstein, R.; von Andrian, U. H.; Wagner, D. D.; Hartwig, J. H.; Hoffmeister, K. M. Desialylation accelerates platelet clearance following refrigeration and initiates GPIbα metalloproteinase- mediated cleavage in mice. Blood 2011, 119, 1263-1273.
9. Dridi, L.; Seyrantepe, V.; Fougerat, A.; Pan, X.; Bonneil, É.; Thibault, P.; Moreau, A.; Mitchell, G. A.; Heveker, N.; Cairo, C. W.; Issad, T.; Hinek, A.; Pshezhetsky, A. V. Positive Regulation of Insulin Signaling by Neuraminidase 1. Diabetes 2013, in press.
10. Yamaguchi, K.; Shiozaki, K.; Moriya, S.; Koseki, K.; Wada, T.; Tateno, H.; Sato, I.; Asano, M.; Iwakura, Y.; Miyagi, T. Reduced Susceptibility to Colitis-Associated Colon Carcinogenesis in Mice Lacking Plasma Membrane-Associated Sialidase. PLoS One 2012, 7, e41132.
11. Gloster, T. M.; Vocadlo, D. J. Developing inhibitors of glycan processing enzymes as tools for enabling glycobiology. Nat. Chem. Biol. 2012, 8, 683-694.
12. Magesh, S.; Moriya, S.; Suzuki, T.; Miyagi, T.; Ishida, H.; Kiso, M. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: Selective inhibitors of lysosomal sialidase (NEU1). Bioorg. Med. Chem. Lett. 2008, 18, 532-537.
13. Khedri, Z.; Li, Y.; Cao, H.; Qu, J.; Yu, H.; Muthana, M. M.; Chen, X. Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2. Org. Biomol. Chem. 2012, 10, 6112-6120.
14. Li, Y.; Cao, H.; Yu, H.; Chen, Y.; Lau, K.; Qu, J.; Thon, V.; Sugiarto, G.; Chen, X. Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies. Mol. BioSyst. 2011, 7, 1060-1072.
15. Hata, K.; Koseki, K.; Yamaguchi, K.; Moriya, S.; Suzuki, Y.; Yingsakmongkon, S.; Hirai, G.; Sodeoka, M.; Von Itzstein, M.; Miyagi, T. Limited inhibitory effects of oseltamivir and zanamivir on human sialidases. Antimicrob. Agents Chemother. 2008, 52, 3484-3491.
16. Albohy, A.; Mohan, S.; Zheng, R. B.; Pinto, B. M.; Cairo, C. W. Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes. Bioorg. Med. Chem. 2011, 19, 2817-22.
17. Zhang, Y.; Albohy, A.; Smutova, V.; Pshezhetsky, A.; Cairo, C. W. Identification of selective inhibitors of human sialidase isoenzymes using C4, C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogs. J. Med. Chem. 2013, 56, 2948-2958.
18. Zou, Y.; Albohy, A.; Sandbhor, M.; Cairo, C. W. Inhibition of human neuraminidase 3 (NEU3) by C9-triazole derivatives of 2,3-didehydro-N-acetyl- neuraminic acid. Bioorg. Med. Chem. Lett. 2010, 20, 7529-7533.
19. Chavas, L. M. G.; Tringali, C.; Fusi, P.; Venerando, B.; Tettamanti, G.; Kato, R.; Monti, E.; Wakatsuki, S. Crystal structure of the human cytosolic sialidase Neu2 - Evidence for the dynamic nature of substrate recognition. J. Biol. Chem. 2005, 280, 469-475.
20. Markely, L. R. A.; Ong, B. T.; Hoi, K. M.; Teo, G.; Lu, M. Y.; Wang, D. I. C. A high-throughput method for quantification of glycoprotein sialylation. Anal. Biochem. 2010, 407, 128-133.
21. Seyrantepe, V.; Canuel, M.; Carpentier, S.; Landry, K.; Durand, S.; Liang, F.; Zeng, J.; Caqueret, A.; Gravel, R. A.; Marchesini, S.; Zwingmann, C.; Michaud, J.; Morales, C. R.; Levade, T.; Pshezhetsky, A. V. Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage. Hum. Mol. Genet. 2008, 17, 1556-1568.
22. Seyrantepe, V.; Lema, P.; Caqueret, A.; Dridi, L.; Hadj, S. B.; Carpentier, S.; Boucher, F.; Levade, T.; Carmant, L.; Gravel, R. A.; Hamel, E.; Vachon, P.; Di Cristo, G.; Michaud, J. L.; Morales, C. R.; Pshezhetsky, A. V. Mice Doubly-Deficient in Lysosomal Hexosaminidase A and Neuraminidase 4 Show Epileptic Crises and Rapid Neuronal Loss. PLoS Genet. 2010, 6, No. e1001118.
23. Takahashi, K.; Mitoma, J.; Hosono, M.; Shiozaki, K.; Sato, C.; Yamaguchi, K.; Kitajima, K.; Higashi, H.; Nitta, K.; Shima, H.; Miyagi, T. Sialidase NEU4 Hydrolyzes Polysialic Acids of Neural Cell Adhesion Molecules and Negatively Regulates Neurite Formation by Hippocampal Neurons. J. Biol. Chem. 2012, 287, 14816-14826.
24. Shiozaki, K.; Yamaguchi, K.; Takahashi, K.; Moriya, S.; Miyagi, T. Regulation of Sialyl Lewis Antigen Expression in Colon Cancer Cells by Sialidase NEU4. J. Biol. Chem. 2011, 286, 21052-21061.
25. Albohy, A.; Li, M. D.; Zheng, R. B.; Zou, C.; Cairo, C. W. Insight into substrate recognition and catalysis by the mammalian neuraminidase 3 (NEU3) through molecular modeling and site directed mutagenesis. Glycobiology 2010, 20, 1127-1138.
26. Pshezhetsky, A. V.; Potier, M. Association of N-Acetylgalactosamine-6- sulfate Sulfatase with the Multienzyme Lysosomal Complex of β- Galactosidase, Cathepsin A, and Neuraminidase. J. Biol. Chem. 1996, 271, 28359-28365.
27. Thompson, J. D.; Higgins, D. G.; Gibson, T. J. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22, 4673-4680.
28. Arnold, K.; Bordoli, L.; Kopp, J.; Schwede, T. The SWISSMODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006, 22, 195-201.
29. Still, W. C.; Tempczyk, A.; Hawley, R. C.; Hendrickson, T. Semianalytical treatment of solvation for molecular mechanics and dynamics. J. Am. Chem. Soc. 1990, 112, 6127-6129.
30. Goodsell, D. S.; Morris, G. M.; Olson, A. J. Automated docking of flexible ligands: Applications of AutoDock. J. Mol. Recognit. 1996, 9, 1-5.
31. Morris, G. M.; Goodsell, D. S.; Halliday, R. S.; Huey, R.; Hart, W. E.; Belew, R. K.; Olson, A. J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 1998, 19, 1639-1662.
32. The PyMOL Molecular Graphics System, Version 1.5.0.4; Schrodinger, LLC: http://www.pymol.org/ (November 15, 2012).
33. Gilson, M. K.; Sharp, K. A.; Honig, B. H. Calculating the electrostatic potential of molecules in solution: Method and error assessment. J. Comput. Chem. 1988, 9, 327-335.